Royal Bank of Canada’s LYRA THERAPEUTICS INC LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,953
| Closed | -$6K | – | 7444 |
|
|
2025
Q4 | $6K | Buy |
1,953
+628
| +47% | +$3.13K | ﹤0.01% | 6645 |
|
|
2025
Q3 | $9K | Buy |
1,325
+223
| +20% | +$1.64K | ﹤0.01% | 6527 |
|
|
2025
Q2 | $10K | Buy |
1,102
+942
| +589% | +$7.82K | ﹤0.01% | 6482 |
|
|
2025
Q1 | $1K | Buy |
160
+54
| +51% | +$505 | ﹤0.01% | 6680 |
|
|
2024
Q4 | $2K | Sell |
106
-17
| -14% | -$187 | ﹤0.01% | 6714 |
|
|
2024
Q3 | $1K | Buy |
123
+26
| +27% | +$382 | ﹤0.01% | 6722 |
|
|
2024
Q2 | $1K | Buy |
97
+84
| +646% | +$9.5K | ﹤0.01% | 6849 |
|
|
2024
Q1 | $4K | Sell |
13
-53
| -80% | -$14.1K | ﹤0.01% | 6513 |
|
|
2023
Q4 | $17K | Buy |
66
+1
| +2% | +$181 | ﹤0.01% | 6360 |
|
|
2023
Q3 | $13K | Buy |
65
+64
| +6,400% | +$11.4K | ﹤0.01% | 6337 |
|
|
2023
Q2 | $0 | Buy |
+1
| New | +$139 | ﹤0.01% | 7478 |
|
|
2023
Q1 | – | Sell |
-10
| Closed | -$2K | – | 7303 |
|
|
2022
Q4 | $2K | Buy |
10
+7
| +233% | +$1.39K | ﹤0.01% | 6937 |
|
|
2022
Q3 | $1K | Buy |
+3
| New | +$887 | ﹤0.01% | 7217 |
|
|
2022
Q2 | – | Sell |
-2
| Closed | -$544 | – | 7567 |
|
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 7904 |
|
|
2021
Q4 | $0 | Sell |
2
-4
| -67% | -$1.28K | ﹤0.01% | 7802 |
|
|
2021
Q3 | $3K | Sell |
6
-2
| -25% | -$756 | ﹤0.01% | 7267 |
|
|
2021
Q2 | $3K | Sell |
8
-36
| -82% | -$16.4K | ﹤0.01% | 7184 |
|
|
2021
Q1 | $25K | Sell |
44
-3
| -6% | -$1.87K | ﹤0.01% | 6302 |
|
|
2020
Q4 | $27K | Buy |
+47
| New | +$26.5K | ﹤0.01% | 5928 |
|
Other funds holding LYRA
Royal Bank of Canada's LYRA Position: Q1 2026 in Review
Royal Bank of Canada sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 1,953 shares — an estimated $6K sold.
Royal Bank of Canada first reported a position in LYRA in Q4 2020 and held it in 19 quarters. The position peaked at $27K in Q4 2020. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.
- Royal Bank of Canada reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
- Royal Bank of Canada sold 1,953 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $6K.
- Royal Bank of Canada first reported a position in LYRA THERAPEUTICS INC in Q4 2020 and held it in 19 quarters.
- Royal Bank of Canada's LYRA THERAPEUTICS INC position peaked at $27K in Q4 2020.
- 1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.